Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index |  Total Docs. (2009) |
Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 156 | Advances in Antiviral Drug Design | book series | 0.523 Q1 | 12 | 0 | 7 | 0 | 14 | 6 | 2.00 | 0.00 |  |
| 155 | Alimentary Pharmacology and Therapeutics Symposium Series | journal | 0.186 Q2 | 8 | 0 | 56 | 0 | 19 | 56 | 0.00 | 0.00 | |
| 154 | American Journal of Drug Delivery | journal | 0.452 Q3 | 23 | 0 | 28 | 0 | 39 | 24 | 0.00 | 0.00 | |
| 153 | Chemical Speciation and Bioavailability | journal | 0.351 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 152 | Drugs in Context | journal | 0.101 Q4 | 36 | 0 | 79 | 0 | 1 | 62 | 0.00 | 0.00 | |
| 151 | Drugs in R and D | journal | 0.560 Q2 | 54 | 0 | 121 | 0 | 284 | 120 | 2.44 | 0.00 | |
| 150 | Future HIV Therapy | journal | 0.191 Q3 | 8 | 0 | 57 | 0 | 20 | 46 | 0.35 | 0.00 | |
| 149 | International Journal of Neuroprotection and Neuroregeneration | journal | 0.134 Q4 | 5 | 0 | 55 | 0 | 13 | 48 | 0.10 | 0.00 | |
| 148 | Paediatric and Perinatal Drug Therapy | journal | 0.192 Q3 | 20 | 0 | 59 | 0 | 37 | 50 | 0.70 | 0.00 | |
| 147 | Signal | journal | 0.102 Q4 | 1 | 0 | 12 | 0 | 0 | 10 | 0.00 | 0.00 | |
| 146 | Toxicological Reviews | journal | 0.823 Q2 | 49 | 0 | 20 | 0 | 106 | 20 | 0.00 | 0.00 | |
| 145 | Journal of Clinical Research | journal | 0.129 Q4 | 12 | 2 | 6 | 23 | 1 | 6 | 0.25 | 11.50 | |
| 144 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 4 | 0 | 180 | 0 | 0 | 0.00 | 45.00 | | |
| 143 | ONdrugDelivery | trade journal | 7 | 4 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | | |
| 142 | Journal of Immune Based Therapies and Vaccines | journal | 0.419 Q3 | 21 | 5 | 26 | 216 | 39 | 26 | 1.79 | 43.20 | |
| 141 | Drug Discovery Today: Technologies | journal | 0.264 Q3 | 62 | 6 | 103 | 222 | 94 | 93 | 0.23 | 37.00 | |
| 140 | BMC Chemical Biology | journal | 0.634 Q2 | 21 | 7 | 8 | 330 | 15 | 8 | 1.80 | 47.14 | |
| 139 | Drug Discovery Today: Disease Mechanisms | journal | 0.400 Q3 | 28 | 9 | 154 | 431 | 114 | 140 | 0.89 | 47.89 | |
| 138 | Journal of Applied Therapeutic Research | journal | 0.131 Q4 | 8 | 10 | 21 | 215 | 8 | 21 | 0.44 | 21.50 | |
| 137 | Journal of Nanobiotechnology | journal | 1.490 Q1 | 109 | 10 | 39 | 361 | 177 | 37 | 5.44 | 36.10 | |
| 136 | Journal of Negative Results in BioMedicine | journal | 0.372 Q1 | 25 | 12 | 41 | 409 | 76 | 41 | 1.32 | 34.08 | |
| 135 | Antiviral Chemistry and Chemotherapy | journal | 0.530 Q2 | 59 | 17 | 79 | 891 | 154 | 77 | 2.12 | 52.41 | |
| 134 | Autonomic and Autacoid Pharmacology | journal | 0.319 Q3 | 24 | 17 | 103 | 935 | 87 | 102 | 1.03 | 55.00 | |
| 133 | Issues in Toxicology | book series | 0.197 Q3 | 18 | 18 | 51 | 1596 | 15 | 47 | 0.29 | 88.67 | |
| 132 | BMC Clinical Pharmacology | journal | 0.599 Q2 | 43 | 19 | 34 | 679 | 84 | 34 | 2.46 | 35.74 | |
| 131 | BMC Pharmacology | journal | 0.620 Q2 | 48 | 19 | 53 | 530 | 96 | 53 | 1.41 | 27.89 | |
| 130 | Quality Assurance Journal | journal | 0.122 Q4 | 11 | 21 | 52 | 202 | 8 | 43 | 0.19 | 9.62 | |
| 129 | Drug Discovery Today: Disease Models | journal | 0.264 Q3 | 33 | 22 | 137 | 950 | 66 | 121 | 0.38 | 43.18 | |
| 128 | Drug Discovery Today: Therapeutic Strategies | journal | 0.300 Q3 | 31 | 22 | 165 | 901 | 124 | 150 | 0.46 | 40.95 | |
| 127 | Chinese Medicine | journal | 0.617 Q2 | 56 | 24 | 34 | 1143 | 91 | 32 | 2.40 | 47.63 | |
| 126 | Food Additives and Contaminants: Part B Surveillance | journal | 0.267 Q4 | 41 | 25 | 22 | 652 | 16 | 21 | 0.73 | 26.08 | |
| 125 | International Journal of Computational Biology and Drug Design | journal | 0.141 Q4 | 16 | 25 | 30 | 759 | 9 | 30 | 0.30 | 30.36 | |
| 124 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.728 Q1 | 99 | 25 | 69 | 3489 | 351 | 64 | 4.20 | 139.56 | |
| 123 | Mathematical Medicine and Biology | journal | 0.620 Q2 | 49 | 26 | 62 | 1023 | 105 | 61 | 1.26 | 39.35 | |
| 122 | Pharmacy in Practice | journal | 0.141 Q4 | 6 | 26 | 173 | 313 | 5 | 148 | 0.03 | 12.04 | |
| 121 | Environmental Pollutants and Bioavailability | journal | 39 | 28 | 54 | 930 | 47 | 54 | 0.80 | 33.21 | | |
| 120 | European Pharmaceutical Review | trade journal | 9 | 29 | 0 | 402 | 0 | 0 | 0.00 | 13.86 | | |
| 119 | Particle and Fibre Toxicology | journal | 2.160 Q1 | 119 | 31 | 49 | 1670 | 331 | 46 | 5.18 | 53.87 | |
| 118 | Cutaneous and Ocular Toxicology | journal | 0.348 Q3 | 37 | 32 | 92 | 901 | 120 | 91 | 1.37 | 28.16 | |
| 117 | Pharmaceutical Statistics | journal | 1.283 Q1 | 46 | 32 | 90 | 745 | 133 | 79 | 1.59 | 23.28 | |
| 116 | Toxin Reviews | journal | 0.158 Q4 | 54 | 32 | 64 | 1815 | 35 | 60 | 0.51 | 56.72 | |
| 115 | Journal of Occupational Medicine and Toxicology | journal | 0.394 Q3 | 47 | 33 | 88 | 946 | 174 | 88 | 1.57 | 28.67 | |
| 114 | Therapeutic Advances in Neurological Disorders | journal | 0.110 Q4 | 68 | 33 | 18 | 2252 | 9 | 13 | 0.50 | 68.24 | |
| 113 | Molecular Diagnosis and Therapy | journal | 0.754 Q2 | 68 | 34 | 123 | 2398 | 314 | 117 | 2.54 | 70.53 | |
| 112 | Nanotoxicology | journal | 1.478 Q1 | 107 | 34 | 51 | 1379 | 290 | 50 | 5.69 | 40.56 | |
| 111 | BioDrugs | journal | 1.124 Q1 | 79 | 35 | 126 | 2782 | 442 | 117 | 4.24 | 79.49 | |
| 110 | CNS Neuroscience and Therapeutics | journal | 0.839 Q2 | 91 | 35 | 31 | 2080 | 84 | 30 | 2.71 | 59.43 | |
| 109 | Journal of Generic Medicines (discontinued) | journal | 0.205 Q3 | 16 | 35 | 128 | 470 | 29 | 119 | 0.13 | 13.43 | |
| 108 | Pharmaceutical Medicine | journal | 0.149 Q4 | 25 | 36 | 141 | 566 | 52 | 126 | 0.40 | 15.72 | |
| 107 | Cardiovascular Therapeutics | journal | 0.927 Q2 | 54 | 37 | 32 | 1698 | 93 | 28 | 2.91 | 45.89 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data